Answers are grounded in this paper and cite their sources.
Carbapenem-resistant Enterobacterales are a recognized health threat worldwide, due to high morbidity and mortality rates. After the COVID-19 pandemic, some geographic regions faced an increase in NDM-producing as well as NDM and KPC-co-producing Enterobacterales. Some of these species are intrinsically resistant to polymyxins, limiting significantly therapeutic options. This retrospective study analyzed 347 Enterobacterales resistant or intermediate to meropenem recovered between 2019 and 2023 from patients attending in a tertiary care hospital. The presence of carbapenemases and the susceptibility to ceftazidime-avibactam were assessed. Among members of Morganellaceae, 41.7% were resistant to meropenem while 58.2% were intermediate; most isolates (93.2%) produced NDM. On the other hand, among Serratia spp., resistance to meropenem was higher (78.7%) and isolates produced predominantly KPC (90.6%). Resistance to CAZ-AVI was not observed among isolates producing serine-carbapenemases. Our results reinforce the need for new therapeutic options to treat infections caused by gram-negative bacilli producing metallo-beta-lactamases, especially those intrinsically resistant to polymyxins.
No takes yet. Share an insight, caveat, or question.
Moreira et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: